CRCGN015_MCF10A.TP53.M_24H:H17 Gene Set
Genes
28 genes differentially expressed following the CRCGN015_MCF10A.TP53.M_24H:H17 small molecule perturbation from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
increased expression
| Symbol |
Name |
Standardized Value |
|
ST3GAL5
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 5
|
5.619
|
|
SSBP2
|
single-stranded DNA binding protein 2
|
5.06878
|
|
RAP1GAP
|
RAP1 GTPase activating protein
|
5.05545
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
4.7989
|
|
POLD4
|
polymerase (DNA-directed), delta 4, accessory subunit
|
4.6114
|
|
CNRIP1
|
cannabinoid receptor interacting protein 1
|
3.7215
|
|
SLC25A13
|
solute carrier family 25 (aspartate/glutamate carrier), member 13
|
3.5529
|
|
ACAA1
|
acetyl-CoA acyltransferase 1
|
3.5126
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
3.21485
|
|
TLCD3A
|
TLC domain containing 3A
|
3.10935
|
|
NFATC3
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3
|
2.93763
|
|
IARS2
|
isoleucyl-tRNA synthetase 2, mitochondrial
|
2.8217
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
2.1945
|
decreased expression
| Symbol |
Name |
Standardized Value |
|
RNF167
|
ring finger protein 167
|
-5.4417
|
|
CCNB1
|
cyclin B1
|
-5.3199
|
|
SLC25A46
|
solute carrier family 25, member 46
|
-5.05555
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
-4.70725
|
|
BASP1
|
brain abundant, membrane attached signal protein 1
|
-4.2446
|
|
CANT1
|
calcium activated nucleotidase 1
|
-4.11172
|
|
KCNK1
|
potassium channel, two pore domain subfamily K, member 1
|
-2.79085
|
|
KRT14
|
keratin 14, type I
|
-2.4258
|
|
ZMYM2
|
zinc finger, MYM-type 2
|
-2.20792
|
|
ATP11B
|
ATPase, class VI, type 11B
|
-2.08055
|
|
BEST1
|
bestrophin 1
|
-2.077
|
|
GRN
|
granulin
|
-2.07245
|
|
CDH15
|
cadherin 15, type 1, M-cadherin (myotubule)
|
-2.06153
|
|
TNPO1
|
transportin 1
|
-2.02219
|
|
ZBTB22
|
zinc finger and BTB domain containing 22
|
-2.00915
|
